Phathom Pharmaceuticals, Inc. (PHAT)
$8.66-2.37%Close
SELLCRISIS · day 18
Key stats
Short interest · FINRA settlement 2026-07-31
- Market cap
- $691M
- Avg volume
- 1.3M
- Beta
- 0.50
- P/E (TTM)
- -6.77
- Short % float
- 20.70%
- Days to cover
- 8.7
- SI change
- +9.9%
- 1W
- -6.68%
- 1M
- -24.30%
- 3M
- -23.57%
- YTD
- -44.88%
- vs SPY 1W
- -5.49%
- vs SPY 1M
- -27.62%
- vs SPY 3M
- -25.96%
- vs SPY YTD
- -56.63%
Sector peers
Same-sector names ranked by LOPJLB quality proximity · Healthcare
- PPBTBUYPurple Biotech Ltd.RECOVERYQ -16$1.56-0.64%
- BIIBBUYBiogen Inc.BULLQ 19$218.12+0.62%
- PLRXBUYPliant Therapeutics, Inc.RECOVERYQ -7$1.14-1.72%
- LMRIBUYLumexa Imaging Holdings, Inc. Common StockQ -28$11.85-4.59%
- RCKTSELLRocket Pharmaceuticals, Inc.RECOVERYQ 6$3.53+0.57%
- BRKRSELLBruker CorporationRECOVERYQ 8$56.98-4.33%
- DWTXBUYDogwood Therapeutics, Inc.RECOVERYQ -13$2.56+2.81%
- CLDISELLCalidi Biotherapeutics, Inc.CRISISQ -30$1.38+2.99%
- ALDXSELLAldeyra Therapeutics, Inc.RECOVERYQ -4$1.52+0.00%
- APGEBUYApogee Therapeutics, Inc.BULLQ 60$134.79+0.03%
- ATTOFLATAttovia Therapeutics, Inc.Q 18$20.62-0.87%
- BMEABUYBiomea Fusion, Inc.RECOVERYQ -5$1.59+16.06%
Industry peers
FMP comparable companies · ranked by market cap
- NRIXBUYNurix Therapeutics, Inc.$2.8BBULLQ 13$27.05-1.68%
- KODSELLKodiak Sciences Inc.$2.5BCRISISQ 37$39.84-2.90%
- URGNBUYUroGen Pharma Ltd.$2.3BBULLQ 23$46.80-1.49%
- XNCRBUYXencor, Inc.$2.0BBULLQ 17$27.00+4.32%
- SEPNBUYSepterna Inc$1.8BCRISISQ 29$40.79+1.30%
- ANABBUYAnaptysBio, Inc.$1.7BRECOVERYQ 27$56.69+1.21%
- BCAXSELLBicara Therapeutics Inc. Common Stock$1.6BCRISISQ 0$24.39-1.34%
- SANABUYSana Biotechnology, Inc.$1.0BRECOVERYQ -4$3.74-3.32%
- OCSBUYOculis Holding AG$751MRECOVERYQ 5$13.14+0.69%
- BBOTBUYBridgeBio Oncology Therapeutics Inc.$727MRECOVERYQ 3$9.08+0.66%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 18
- VALUE
- 11
- GROWTH
- 37
- GARP
- 5
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC15.4%
REV YoY-
ROE25.7%
EPS YoY-
ROA-30.3%
GROSS83
OP-17
NET-41
[VALUATION]
P/E TTM-6.77
P/E FWD-
SECTOR PE22.66
INDUSTRY PE17.07
P/B-2.11
P/FCF-
EV/EBITDA-19.50
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E-
ALTMAN Z-
CURR RATIO1.92
ND/EBITDA-
BETA0.50
